The bioequivalence of highly variable drugs and drug products.
…, MJ Rawson, JW Hubbard - International Journal of …, 2005 - search.ebscohost.com
Highly variable drugs' have been defined as those drugs for which the within-subject variability
(WSV) equals or exceeds 30% of the maximum concentration (C max ) and/or the area …
(WSV) equals or exceeds 30% of the maximum concentration (C max ) and/or the area …
At issue: defining treatment refractoriness in schizophrenia
…, SJ Dencker, MJ Goldstein, JW Hubbard… - Schizophrenia …, 1990 - academic.oup.com
Addressing the need for research on the nature of refractoriness to antipsychotic drug
therapy exhibited by a substantial minority of schizophrenic patients, Philip RA May and Sven …
therapy exhibited by a substantial minority of schizophrenic patients, Philip RA May and Sven …
Enantioselective pharmacokinetics and pharmacodynamics of dl‐thero‐mcthylphenidate in children with attention deficit hyperactivity disorder
NR Srinivas, JW Hubbard, D Quinn… - Clinical Pharmacology …, 1992 - Wiley Online Library
… Lim HK, Hubbard JW, Midha KK. Development of enantioselective gas chromatographic
quantitation assay for dl-threo-methylphenidate in biological fluids. J Chromatogr l986;378: 109-…
quantitation assay for dl-threo-methylphenidate in biological fluids. J Chromatogr l986;378: 109-…
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia
…, E Amico, O Sarid-Segal, KK Midha, JW Hubbard - …, 1995 - Springer
Following a 2-week placebo lead-in, schizophrenic patients were randomly assigned to
fluoxetine 20 mg/day or placebo added to depot neuroleptic for a 6-week, double blind trial. All …
fluoxetine 20 mg/day or placebo added to depot neuroleptic for a 6-week, double blind trial. All …
Pharmacokinetics of chlorpromazine and key metabolites
PKF Yeung, JW Hubbard, ED Korchinski… - European journal of …, 1993 - Springer
A study was carried out in 11 healthy young men to investigate the pharmacokinetics of
chlorpromazine (CPZ) after a bolus intravenous (IV) dose (10 mg) and three single oral doses (25…
chlorpromazine (CPZ) after a bolus intravenous (IV) dose (10 mg) and three single oral doses (25…
The role of metabolites in bioequivalence
KK Midha, MJ Rawson, JW Hubbard - Pharmaceutical research, 2004 - Springer
… McKay, MJ Rawson, ED Korchinski, and JW Hubbard. Effects of food on the pharmacokinetics
of … YZ Shu, JW Hubbard, JK Cooper, G. McKay, ED Korchinski, R. Kumar, and KK Midha. …
of … YZ Shu, JW Hubbard, JK Cooper, G. McKay, ED Korchinski, R. Kumar, and KK Midha. …
Enantioselective Pharmacokinetics of dl-threo-Methylphenidate in Humans
NR Srinivas, JW Hubbard, ED Korchinski… - Pharmaceutical …, 1993 - Springer
… HK Lim, JW Hubbard, and KK Midha. Development of enantioselective gas … NR
Srinivas, JW Hubbard, and KK Midha. Enantioselective gas chromatographic assay with …
Srinivas, JW Hubbard, and KK Midha. Enantioselective gas chromatographic assay with …
[HTML][HTML] Dielectric anomalies due to grain boundary conduction in chemically substituted BiFeO3
…, A Kumar, SP Pavunny, JW Hubbard… - Journal of Applied …, 2015 - pubs.aip.org
We describe systematic studies on Nd and Mn co-doped BiFeO 3, ie,(Bi 0.95 Nd 0.05)(Fe 0.97
Mn 0.03) O 3 (BNFM) polycrystalline electroceramics. Raman spectra and X-ray diffraction …
Mn 0.03) O 3 (BNFM) polycrystalline electroceramics. Raman spectra and X-ray diffraction …
Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications
SR Marder, JW Hubbard, T Van Putten, KK Midha - Psychopharmacology, 1989 - Springer
The authors review the literature regarding the pharmacokinetics of long-acting injectable
neuroleptic drugs (LINS). There are important differences between LINS and oral neurolepties …
neuroleptic drugs (LINS). There are important differences between LINS and oral neurolepties …
Evaluation of the bioequivalence of highly-variable drugs and drug products
…, KK Midha, MJ Rawson, JW Hubbard - Pharmaceutical …, 2001 - Springer
Purpose. To establish procedures for the effective evaluation of bioequivalence (BE) for
highly-variable drugs and drug products (HVD/P). Methods. 2- and 4-period crossover BE …
highly-variable drugs and drug products (HVD/P). Methods. 2- and 4-period crossover BE …